文献速递慢阻肺

COPD亚群死因别死亡率:英国339647人队列研究

Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England.
PubMed 文献 · Thorax · 2024-02-15

气流受限程度、GOLD分组、急性加重频率与严重度及COPD表型与全因死亡率相关;GOLD分组B-D及气流受限加重与COPD和心血管死亡风险升高相关。

要点

  • 急性加重频率和严重度与COPD相关死亡风险升高独立相关。
  • GOLD分组B-D及气流受限加重与COPD和心血管死亡风险升高相关。
  • 不同死因关联模式不同,提示干预需针对特定特征或疾病阶段。

核心结论

  • 气流受限越差、功能状态越差及急性加重与全因死亡风险存在显著关联。
  • 心血管与COPD相关死亡的不同结果提示预防死亡的干预可能需要针对特定特征或疾病时间点。

研究设计与样本

  • 基于英国临床实践研究数据链Aurum数据库的队列研究,链接医院统计和死亡证明数据。

临床怎么用

  • 对COPD患者应评估急性加重频率与严重度、GOLD分组及气流受限程度以分层死亡风险。
  • 针对频繁或严重急性加重及高GOLD分组的患者,可能需要加强干预以降低死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Identifying correlates of cause-specific mortality in patients with chronic obstructive pulmonary disease (COPD) may aid the targeting of therapies to reduce mortality. We determined factors associated with causes of death in a primary care COPD population. METHODS: Clinical Practice Research Datalink Aurum was linked to Hospital Episode Statistics and death certificate data. People with COPD alive between 1 January 2010 and 1 January 2020 were included. Patient characteristics were defined before the start of follow-up: (a) frequency and severity of exacerbations; (b) emphysema or chronic bronchitis; (c) Global Obstructive Lung Disease (GOLD) groups A-D; and (d) airflow limitation. We used Cox Proportional Hazards regression and competing risks to investigate the association between patient characteristics and risk of all-cause, COPD and cardiovascular (CV) mortality. RESULTS: 339 647 people with COPD were included of which 97 882 died during follow-up (25.7% COPD related and 23.3% CV related). Airflow limitation, GOLD group, exacerbation frequency and severity, and COPD phenotype were associated with all-cause mortality. Exacerbations, both increased frequency and severity, were associated with COPD-related mortality (≥2 exacerbations vs none adjusted HR: 1.64, 1.57-1.71; 1 severe vs none adjusted HR: 2.17, 2.04-2.31, respectively). Patients in GOLD groups B-D had a higher risk of COPD and CV mortality compared with GOLD group A (GOLD group D vs group A, adjusted HR for COPD mortality: 4.57, 4.23-4.93 and adjusted HR for CV mortality: 1.53, 1.41-1.65). Increasing airflow limitation was also associated with both COPD and CV mortality (GOLD 4 vs 1, adjusted HR: 12.63, 11.82-13.51 and adjusted HR: 1.75, 1.60-1.91, respectively). CONCLUSION: Poorer airflow limitation, worse functional status and exacerbations had substantial associations with risk of all-cause mortality. Differing results for CV and COPD-related mortality suggests interventions to prevent mortality may need to target particular characteristics or time points in the disease course.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Whittaker, Rothnie, Quint, et al. Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax. 2024. PMID: 37328279. doi:10.1136/thorax-2022-219320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。